Holen Sie sich die Stockscreener-App
14.23
3.27%
0.45
Handel nachbörslich:
14.23
Schlusskurs vom Vortag:
$13.78
Offen:
$13.71
24-Stunden-Volumen:
560.94K
Relative Volume:
1.32
Marktkapitalisierung:
$655.96M
Einnahmen:
$524.73M
Nettoeinkommen (Verlust:
$31.70M
KGV:
21.51
EPS:
0.6617
Netto-Cashflow:
$22.47M
1W Leistung:
-15.15%
1M Leistung:
-12.86%
6M Leistung:
-9.36%
1J Leistung:
+18.09%
1-Tages-Spanne:
$13.71
$14.51
1-Wochen-Bereich:
$13.39
$17.30
52-Wochen-Spanne:
$9.72
$20.36
Core Laboratories Inc Stock (CLB) Company Profile
Firmenname
Core Laboratories Inc
Sektor
Telefon
713-328-2673
Adresse
6316 WINDFERN ROAD, HOUSTON
Compare CLB vs SLB, BKR, HAL, TS, FTI
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLB
Core Laboratories Inc
|
14.23 | 635.21M | 524.73M | 31.70M | 22.47M | 0.6617 |
SLB
Slb Ltd
|
56.00 | 83.17B | 35.91B | 3.38B | 4.41B | 2.2806 |
BKR
Baker Hughes Company
|
67.78 | 68.46B | 27.89B | 3.15B | 2.29B | 3.1363 |
HAL
Halliburton Co
|
41.72 | 35.07B | 22.17B | 1.55B | 1.68B | 1.8227 |
TS
Tenaris Sa Adr
|
63.48 | 31.45B | 12.00B | 1.98B | 2.02B | 3.6742 |
FTI
Technipfmc Plc
|
75.03 | 29.74B | 10.18B | 1.08B | 1.34B | 2.6183 |
Core Laboratories Inc Stock (CLB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-12 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-06-30 | Herabstufung | Citigroup | Neutral → Sell |
| 2023-04-18 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-01-09 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-10-07 | Hochstufung | Citigroup | Sell → Neutral |
| 2022-09-26 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-04-18 | Herabstufung | Piper Sandler | Neutral → Underweight |
| 2021-10-18 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-07-09 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-14 | Herabstufung | Citigroup | Neutral → Sell |
| 2020-12-18 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-11-11 | Bestätigt | Cowen | Market Perform |
| 2020-10-13 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2020-09-29 | Hochstufung | ABN Amro | Sell → Hold |
| 2020-07-16 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2020-04-13 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2020-03-09 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2020-03-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2020-01-31 | Bestätigt | Cowen | Market Perform |
| 2020-01-30 | Fortgesetzt | Johnson Rice | Buy |
| 2020-01-14 | Eingeleitet | Bernstein | Mkt Perform |
| 2020-01-02 | Herabstufung | Stifel | Buy → Hold |
| 2019-12-31 | Bestätigt | Cowen | Market Perform |
| 2019-07-10 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-02-25 | Hochstufung | Tudor Pickering | Hold → Buy |
| 2018-12-19 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2018-12-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2018-11-16 | Hochstufung | Guggenheim | Neutral → Buy |
| 2018-11-01 | Hochstufung | ABN Amro | Sell → Buy |
| 2018-10-29 | Bestätigt | Cowen | Market Perform |
Alle ansehen
Core Laboratories Inc Aktie (CLB) Neueste Nachrichten
Core Laboratories (NYSE: CLB) SVP exercises restricted shares, covers taxes - Stock Titan
Core Laboratories Q1 Earnings Meet Estimates, Decline Y/Y - Yahoo Finance
Top 3 Energy Stocks That May Jump In Q2 - Benzinga
MSN Money - MSN
Core Lab projects Q2 2026 revenue of $123M-$131M and EPS of $0.06-$0.12 amid Middle East disruptions - MSN
Core Laboratories Inc. Q1 2026 SEC 10-Q Report: Financial Statements, Risk Factors, and Management Analysis - Minichart
Core Laboratories Earnings Call: Tech Strengths Amid Turmoil - The Globe and Mail
Core Laboratories (NYSE:CLB) Shares Down 6.7%Time to Sell? - MarketBeat
Why Core Laboratories (CLB) Shares Are Sliding Today - TradingView
Core Laboratories Inc (CLB) Q1 2026 Earnings Call Highlights: Na - GuruFocus
Core Laboratories Q1 Earnings Call Highlights - MarketBeat
Core Laboratories (NYSE: CLB) Q1 2026 revenue slips and results swing to loss - Stock Titan
Core Laboratories : 2025 Core Laboratories Annual Report - marketscreener.com
Core Laboratories (NYSE:CLB) Shares Gap DownWhat's Next? - MarketBeat
Earnings call transcript: Core Laboratories Q1 2026 results miss expectations By Investing.com - Investing.com Canada
Core Laboratories Inc. (NYSE:CLB) to Issue Quarterly Dividend of $0.01 - MarketBeat
Core Laboratories N.V. Q1 2026 Earnings Call Summary - Yahoo Finance
Middle East conflict weighs on Core Laboratories' Q1 outlook - MSN
Core Laboratories Inc (CLB) Q1 2026 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
Core Lab (CLB) Reports Q1 Revenue Amid Geopolitical Challenges - GuruFocus
Is Core Laboratories (CLB) 8.2% Undervalued After Q1 2026? Adj. - GuruFocus
Core Laboratories (NYSE:CLB) Issues Q2 2026 Earnings Guidance - MarketBeat
Core Laboratories Posts Flat Q1 2026 Results Amid Disruptions - TipRanks
Core Laboratories (NYSE:CLB) Announces Earnings Results - MarketBeat
Earnings Flash (CLB) Core Laboratories Inc. Reports Q1 Revenue $121.8M, vs. FactSet Est of $123.0M - marketscreener.com
Core Laboratories: Q1 Earnings Snapshot - Barchart.com
Core Laboratories Inc. Approves Cash Dividend, Payable on June 1, 2026 - marketscreener.com
Core Laboratories recently disclosed that the ongoing conflict in the Middle East has had a substantial impact on its client activities and regional operations. - Bitget
Core Laboratories’s (NYSE:CLB) Q1 CY2026: Beats On Revenue - Barchart.com
Core Laboratories Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Core Laboratories (NYSE: CLB) posts Q1 loss, guides Q2 EPS to $0.06–$0.12 - Stock Titan
Core Laboratories (CLB) To Report Earnings Tomorrow: Here Is What To Expect - Yahoo Finance
Q3 EPS Estimate for Core Laboratories Lowered by Analyst - MarketBeat
Core Laboratories to Post Q1 Earnings: Key Metrics to Watch - Zacks Investment Research
Earnings Preview: Core Laboratories (CLB) Q1 Earnings Expected to Decline - Yahoo Finance
Core Laboratories (CLB) Projected to Post Earnings on Wednesday - MarketBeat
Core Laboratories (CLB) Price Target Increased by 11.51% to 15.64 - MSN
Core Labs (CLB) Stock Earnings Report (Weakens) 2026-04-20Crowd Entry Points - Newser
Core Laboratories Inc stock (NL0015000CZ2): Why Google Discover changes matter more now - AD HOC NEWS
What's in Store for Core Laboratories Stock in Q4 Earnings? - Eastern Progress
Core Laboratories Inc stock (NL0015000CZ2): Why Google Discover changes matter more now for oilfield - AD HOC NEWS
Core Laboratories Stock Forecast What Is Driving Recent Momentum - Kalkine Media
Core Laboratories (NYSE:CLB) Shares Cross Above 200-Day Moving AverageHere's What Happened - MarketBeat
Retail Surge: Is Core Laboratories Inc part of any major index2026 Rallies & Weekly Breakout Watchlists - baoquankhu1.vn
Update Recap: Will Core Laboratories Inc announce a stock splitQuarterly Risk Review & High Conviction Buy Zone Alerts - baoquankhu1.vn
Insider Sell: Can Core Laboratories Inc be the next market leaderTrade Exit Report & Weekly Top Gainers Trade List - baoquankhu1.vn
Is Core Labs (CLB) Stock overvalued relative to peers | Price at $16.43, Down 1.08%Professional Trade Ideas - Xã Châu Thành
Core Laboratories (NYSE:CLB) Updates Q1 2026 Earnings Guidance - MarketBeat
Core Laboratories (CLB) director gains restricted stock and 8,069 shares vest - Stock Titan
Press Releases about Core Laboratories Inc. Common Stock (NYSE:CLB) - FinancialContent
Finanzdaten der Core Laboratories Inc-Aktie (CLB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.68%
4.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):